Sahra Borgés

576 total citations
13 papers, 432 citations indexed

About

Sahra Borgés is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sahra Borgés has authored 13 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Sahra Borgés's work include Cancer-related gene regulation (3 papers), Epigenetics and DNA Methylation (2 papers) and Cancer Cells and Metastasis (2 papers). Sahra Borgés is often cited by papers focused on Cancer-related gene regulation (3 papers), Epigenetics and DNA Methylation (2 papers) and Cancer Cells and Metastasis (2 papers). Sahra Borgés collaborates with scholars based in United States, France and Switzerland. Sahra Borgés's co-authors include Peter Störz, Heike Döppler, Nisha Durand, E. Aubrey Thompson, Xochiquetzal J. Geiger, Edith A. Perez, Panos Z. Anastasiadis, Derek C. Radisky, Zhifu Sun and Peter E. Lobie and has published in prestigious journals such as PLoS ONE, Nature Cell Biology and Cancer Research.

In The Last Decade

Sahra Borgés

13 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sahra Borgés United States 11 316 141 89 68 48 13 432
Yong‐Jian Deng China 12 237 0.8× 153 1.1× 108 1.2× 53 0.8× 44 0.9× 21 424
María Giselle Peters Argentina 10 300 0.9× 177 1.3× 89 1.0× 120 1.8× 51 1.1× 17 469
Melissa Hector-Greene United States 8 463 1.5× 207 1.5× 97 1.1× 82 1.2× 49 1.0× 8 616
Jelena Stanisavljević Spain 7 224 0.7× 196 1.4× 72 0.8× 67 1.0× 30 0.6× 8 377
Kristopher A. Lofgren United States 9 278 0.9× 198 1.4× 88 1.0× 52 0.8× 77 1.6× 20 451
Sara Koenig McLaughlin United States 4 337 1.1× 141 1.0× 133 1.5× 62 0.9× 87 1.8× 4 491
Blandine Deux France 5 267 0.8× 150 1.1× 89 1.0× 77 1.1× 62 1.3× 6 419
Brunella Costanza Belgium 8 279 0.9× 197 1.4× 156 1.8× 63 0.9× 56 1.2× 9 470
Weimin Hu United States 8 305 1.0× 188 1.3× 79 0.9× 88 1.3× 25 0.5× 10 431
Alena Bartáková United States 14 220 0.7× 107 0.8× 109 1.2× 36 0.5× 53 1.1× 23 492

Countries citing papers authored by Sahra Borgés

Since Specialization
Citations

This map shows the geographic impact of Sahra Borgés's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sahra Borgés with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sahra Borgés more than expected).

Fields of papers citing papers by Sahra Borgés

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sahra Borgés. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sahra Borgés. The network helps show where Sahra Borgés may publish in the future.

Co-authorship network of co-authors of Sahra Borgés

This figure shows the co-authorship network connecting the top 25 collaborators of Sahra Borgés. A scholar is included among the top collaborators of Sahra Borgés based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sahra Borgés. Sahra Borgés is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Durand, Nisha, Sahra Borgés, Ligia I. Bastea, et al.. (2018). The phosphorylation status of PIP5K1C at serine 448 can be predictive for invasive ductal carcinoma of the breast. Oncotarget. 9(91). 36358–36370. 4 indexed citations
2.
Durand, Nisha, Sahra Borgés, & Peter Störz. (2016). Protein Kinase D Enzymes as Regulators of EMT and Cancer Cell Invasion. Journal of Clinical Medicine. 5(2). 20–20. 39 indexed citations
3.
Borgés, Sahra, Edith A. Perez, E. Aubrey Thompson, et al.. (2015). Effective Targeting of Estrogen Receptor–Negative Breast Cancers with the Protein Kinase D Inhibitor CRT0066101. Molecular Cancer Therapeutics. 14(6). 1306–1316. 51 indexed citations
4.
Durand, Nisha, Sahra Borgés, & Peter Störz. (2015). Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer. Cellular and Molecular Life Sciences. 72(22). 4369–4382. 25 indexed citations
5.
Kourtidis, Antonis, Siu P. Ngok, Pamela Pulimeno, et al.. (2015). Distinct E-cadherin-based complexes regulate cell behaviour through miRNA processing or Src and p120 catenin activity. Nature Cell Biology. 17(9). 1145–1157. 82 indexed citations
6.
Döppler, Heike, Ligia I. Bastea, Sahra Borgés, Xochiquetzal J. Geiger, & Peter Störz. (2015). The phosphorylation status of VASP at serine 322 can be predictive for aggressiveness of invasive ductal carcinoma. Oncotarget. 6(30). 29740–29752. 12 indexed citations
7.
Borgés, Sahra, Heike Döppler, & Peter Störz. (2014). A combination treatment with DNA methyltransferase inhibitors and suramin decreases invasiveness of breast cancer cells. Breast Cancer Research and Treatment. 144(1). 79–91. 31 indexed citations
8.
Döppler, Heike, et al.. (2014). Protein Kinase D Isoforms Differentially Modulate Cofilin-Driven Directed Cell Migration. PLoS ONE. 9(5). e98090–e98090. 29 indexed citations
9.
Borgés, Sahra, Heike Döppler, Edith A. Perez, et al.. (2013). Pharmacologic reversion of epigenetic silencing of the PRKD1promoter blocks breast tumor cell invasion and metastasis. Breast Cancer Research. 15(2). R66–R66. 64 indexed citations
10.
Borgés, Sahra, et al.. (2012). Abstract P1-05-24: Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.. Cancer Research. 72(24_Supplement). P1–5. 6 indexed citations
11.
Kong, Xiangjun, Nethaji Muniraj, Nagarajan Kannan, et al.. (2009). Trefoil Factor-1 (TFF1) Enhances Oncogenicity of Mammary Carcinoma Cells. Endocrinology. 150(10). 4473–4483. 57 indexed citations
12.
Borgés, Sahra, Elara Moudilou, Jean Chiésa, et al.. (2008). Involvement of a JAK/STAT Pathway Inhibitor: Cytokine Inducible SH2 Containing Protein in Breast Cancer. Advances in experimental medicine and biology. 617. 321–329. 17 indexed citations
13.
Borgés, Sahra, Mireille Raccurt, Cécile Arnould, et al.. (2008). Proteomic Analysis of Autocrine/Paracrine Effects of Human Growth Hormone in Human Mammary Carcinoma Cells. Advances in experimental medicine and biology. 617. 493–500. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yong‐Jian Deng Breakdown of academic impact, for papers by María Giselle Peters Breakdown of academic impact, for papers by Melissa Hector-Greene Breakdown of academic impact, for papers by Jelena Stanisavljević Breakdown of academic impact, for papers by Kristopher A. Lofgren Breakdown of academic impact, for papers by Sara Koenig McLaughlin Breakdown of academic impact, for papers by Blandine Deux Breakdown of academic impact, for papers by Brunella Costanza Breakdown of academic impact, for papers by Weimin Hu Breakdown of academic impact, for papers by Alena Bartáková
Rankless by CCL
2026